- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Washington, DC- On Thursday, July 23rd Americans for Safe Access (ASA) is hosting a Congressional Briefing with Representative Earl Blumenauer (D-OR) on federal barriers faced by researchers working to understand the medical uses of marijuana. The briefing will provide expert insights on how federal policy has undermined medical marijuana research, the state of contemporary medical marijuana research and the impact of reform proposals.
Dr. Sue Sisley will present on how federal barriers have directly blocked her research on using marijuana to treat Post Traumatic Stress Disorder including the adverse impacts of the Drug Enforcement Agency licensing only one entity (National Institute on Drug Abuse) to grow the federal research supply of marijuana. Dr. David Casarett, associate professor at the University of Pennsylvania Perelman School of Medicine and author of the recently published book, Stoned: A Doctor’s Case for Medical Marijuana will discuss contemporary medical marijuana research. The final speaker will be John Hudak, fellow in Governance Studies at the Brookings Institute and Managing Editor of the FixGov blog. Mr. Hudak will be discussing the often misunderstood impact of moving marijuana to a different schedule classification under the Controlled Substances Act.
“With prominent members of Congress calling for more research on medical marijuana, it’s time we start hearing from experts about how to make increased medical marijuana research a reality,” said Steph Sherer ASA Executive Director. “These experts can tell us first hand how the federal government’s policies undermine research and how reforms like the CARERS act can move this essential medical research in area forward.”
What: Congressional Briefing on Federal Barriers to Medical Marijuana Research
Where: Cannon House Office Building Room 340
When: Thursday, July 23 10:30am
Who: Dr. Sue Sisley, Dr. David Casarett, and Brookings Institute Fellow John Hudak